Commission Implementing Regulation (EU) 2023/651 of 20 March 2023 concerning the authorisation of riboflavin (vitamin B2) produced by Bacillus subtilis KCCM 10445 and a preparation of riboflavin produced by Bacillus subtilis KCCM 10445 as feed additives for all animal species
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act marked as EEA relevant by the EU and under scrutiny for incorporation into the EEA Agreement by Iceland, Liechtenstein and Norway Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Legal documents
Commission Implementing Regulation (EU) 2023/651 of 20 March 2023 concerning the authorisation of riboflavin (vitamin B2) produced by Bacillus subtilis KCCM 10445 and a preparation of riboflavin produced by Bacillus subtilis KCCM 10445 as feed additives for all animal species
Durchführungsverordnung (EU) 2023/651 der Kommission vom 20. März 2023 zur Zulassung von Riboflavin (Vitamin B2), hergestellt aus Bacillus subtilis KCCM 10445, und einer Zubereitung aus Riboflavin, hergestellt aus Bacillus subtilis KCCM 10445, als Zusatzstoffe in Futtermitteln für alle Tierarten
History
21.03.2023
Adoption date in the EU
10.04.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.